Faculty profile

Kori Leblanc

Back to faculty

Assistant ProfessorStatusUniversity of Toronto

Kori Leblanc

Assistant Professor

Status

Leslie Dan Faculty of Pharmacy

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
8 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,688

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Development and Evaluation of an AI Avatar Educational Tool for Depression and Anxiety: A Qualitative Pilot Study.
Journal of primary care & community health · 2026
Patient Perceived Barriers and Enablers to Medication Adherence in the Treatment of Depression: A Qualitative Study.
Journal of primary care & community health · 2024
Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus
Cancers · 2024 · first author

All 21 publications

21 publications.

Development and Evaluation of an AI Avatar Educational Tool for Depression and Anxiety: A Qualitative Pilot Study.

Bleik A, Marr P, Li SA, Kwan D, Ji C, Leblanc K, Meng Y, Papoushek C

Journal of primary care & community health20262 citationsOpen Access

DOI: 10.1177/21501319251413030 PMID: 41558678

Patient Perceived Barriers and Enablers to Medication Adherence in the Treatment of Depression: A Qualitative Study.

Meng Y, Chiu C, Kapoor M, Li SA, Kaur N, Marr P, Kwan D, Leblanc K, Ji C, Papoushek C

Journal of primary care & community health20249 citationsOpen Access

DOI: 10.1177/21501319241286313 PMID: 39417387

Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus

Leblanc K, Edwards SJ, Dranitsaris G, Leong DP, Carrier M, Malone S, Rendon RA, Bond AM, Sitland TD, Zalewski P

Cancers20248 citationsFirst authorOpen Access

DOI: 10.3390/cancers16193336

Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics

Goodman SG, Roy D, Pollack CV, Leblanc K, Kwaku KF, Barnes GD, Bonaca MP, Hills MT, Campello E, Fanikos J

Critical Pathways in Cardiology20245 citationsOpen Access

DOI: 10.1097/hpc.0000000000000351

Single center evaluation on the use of conditionally ordered low molecular weight heparins in malignant hematology patients with venous thromboembolism.

Pun H, Pang I, Leblanc K, Dhillon P, McEwan C, Patel P, Kumar R

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners2024

DOI: 10.1177/10781552231189695 PMID: 37501557

Physician and nurse practitioner perspectives of a modified Routine Opioid Outcome Monitoring (ROOM) Tool.

Lam C, Marr P, Leblanc K, Papoushek C, Kwan D, Sproule B, Murphy L

Journal of primary health care20232 citationsOpen Access

DOI: 10.1071/hc23022 PMID: 37756229

Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post-Percutaneous Coronary Intervention.

Poirier CM, Carter AA, Kwan Y, Koo J, Westlund JM, Alkass F, Leblanc K

CJC open2023Senior author

DOI: 10.1016/j.cjco.2023.08.007 PMID: 38020330

Opioid Utilization and Management in the Setting of Stewardship During Inpatient Rehab Care.

Murphy L, Leblanc K, Badr S, Ching E, Mao L, Steenhof N, Hamandi B, Rubin B, Seto A, Furlan AD

Drug, healthcare and patient safety20222 citationsOpen Access

DOI: 10.2147/dhps.s360832 PMID: 36118374

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation

Andrade JG, Aguilar M, Atzema C, Bell A, Cairns JA, Cheung CC, Cox JL, Dorian P, Gladstone DJ, Healey JS

Canadian Journal of Cardiology2020610 citations

DOI: 10.1016/j.cjca.2020.09.001

Non‐vitamin K antagonist oral anticoagulant (NOAC) use and dosing in Canadian practice: Insights from the optimising pharmacotherapy in the management approach to lowering risk in atrial fibrillation (OPTIMAL AF) Programme

Kori Leblanc, Alan David Bell, Justin Adrian Ezekowitz, Mary Tan, David J. Laflamme, Lianne Goldin, Jeffrey Habert, Peter Lin, Kevin O. Saunders, Daniel Ngui, Albert P. Ng, Jacques Desroches, Shaun G. Goodman, for the OPTIMAL AF Investigators

International Journal of Clinical Practice20208 citationsFirst author

DOI: 10.1111/ijcp.13625 PMID: 33448547

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Kori Leblanc

Research

Latest papers

Development and Evaluation of an AI Avatar Educational Tool for Depression and Anxiety: A Qualitative Pilot Study.

Patient Perceived Barriers and Enablers to Medication Adherence in the Treatment of Depression: A Qualitative Study.

Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus

Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics

Single center evaluation on the use of conditionally ordered low molecular weight heparins in malignant hematology patients with venous thromboembolism.

Physician and nurse practitioner perspectives of a modified Routine Opioid Outcome Monitoring (ROOM) Tool.

Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post-Percutaneous Coronary Intervention.

Opioid Utilization and Management in the Setting of Stewardship During Inpatient Rehab Care.

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation

Non‐vitamin K antagonist oral anticoagulant (NOAC) use and dosing in Canadian practice: Insights from the optimising pharmacotherapy in the management approach to lowering risk in atrial fibrillation (OPTIMAL AF) Programme

Frequent collaborators

Paul Dorian

David Gladstone

Laurent Macle

Jeff Healey

Alison Bell

Stanley Nattel

Jeffrey Sean Healey

Mukul Sharma

Atul Verma

Dante Morra

Jason Andrade

Michael McMurtry

Teresa Tsang

Noah Ivers

Subodh Verma

Debbie Kwan

Allan Skanes

Clare Atzema

Louise Pilote

Ratika Parkash

Mario Talajic

Shaun Goodman

Nazanin Meshkat

Naomi Steenhof

Jeffrey Weitz

Sacha Bhatia

Lori MacCallum

William Geerts

Lynda Mao

Cindy Natsheh

John Papastergiou

Bonita Rubin